CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
The effectivness of entecavir in chronic hepatitis B in patients resistant to lamivudine and adefovir
DOI 10.1055/s-2008-1079649
Bibliografische Angaben
Nachweis in CareLit
Autor:innenZ Koutoubi, Á Vincze, A Chebli, M Taha
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background/aims: Entecavir, a nucleoside analog, is a new medication that is active against both lamivudine- and adefovir-resistant HBV. The aim of this study was to investigate the effectiveness of entecavir in patients with chronic hepatitis B resistant to lamivudine and/or adefovir therapy in patients from United Arab Emirates. Methods: In an observational prospective study, we followed 36 patients with chronic h…
Zitieren
Zitierempfehlung
Z Koutoubi, Á Vincze, A Chebli, M Taha (2008) The effectivness of entecavir in chronic hepatitis B in patients resistant to lamivudine and adefovir. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-2008-1079649
Mit CareLit weiterarbeiten